Primary renal allograft dysfunction.
Foster
Kirk
K
Department of Pathology, Columbia University, College of Physicians & Surgeons, New York, NY 10032, USA.
Cohen
David J
DJ
D'Agati
Vivette D
VD
Markowitz
Glen S
GS
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003928:Diabetic Nephropathies / Q000601:surgery; D003937:Diagnosis, Differential; D003951:Diagnostic Errors; D018450:Disease Progression; D004359:Drug Therapy, Combination; D006801:Humans; D007145:Immunoglobulin kappa-Chains / Q000032:analysis; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007668:Kidney / Q000737:chemistry / Q000473:pathology*; D007676:Kidney Failure, Chronic / Q000209:etiology* / Q000473:pathology / Q000601:surgery; D016030:Kidney Transplantation; D007683:Kidney Tubular Necrosis, Acute / Q000175:diagnosis*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D009194:Myeloma Proteins / Q000032:analysis; D011183:Postoperative Complications / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology; D012074:Remission Induction; D006435:Renal Dialysis; D014184:Transplantation, Homologous
D007145:Immunoglobulin kappa-Chains; D007166:Immunosuppressive Agents; D009194:Myeloma Proteins